Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Icosavax, Inc. (ICVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
08/08/2023 8-K Investor presentation
Docs: "Slide Presentation",
"Slide Presentation"
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/23/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Opinion of Latham & Watkins LLP",
"Form of Securities Purchase Agreement"
05/10/2023 8-K Quarterly results
Docs: "Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update"
12/13/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
Docs: "Icosavax Reports Third Quarter Financial Results and Provides Corporate Update"
08/15/2022 8-K Quarterly results
06/28/2022 8-K Quarterly results
06/15/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
04/25/2022 8-K Investor presentation
Docs: "Slide Presentation"
03/30/2022 8-K Quarterly results
Docs: "Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update"
03/25/2022 8-K Other Events  Interactive Data
02/11/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/07/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Icosavax Provides Corporate Update and Anticipated Milestones for 2022"
01/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
12/16/2021 8-K Quarterly results
11/15/2021 8-K Quarterly results
Docs: "Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update"
09/13/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
08/02/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : August 2, 2021 ICOSAVAX, INC. Delaware 001-40655 82-3640549 1616 Eastlake Avenue E., Suite 208 Seattle, Washington 98102 737-0085 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under th...",
"Amended and Restated Certificate of Incorporation of Icosavax, Inc",
"Amended and Restated Bylaws of Icosavax, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy